person

Evangelia N.

Country
Greece
Department
Nephrology Department

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
226
Sites with multiple studies

Has run more than one trial at 226 of 642 partner sites.

Specializations

Renal Medicine and Nephrology

Focus on progressive kidney diseases and related systemic inflammation.

  • Chronic Kidney Disease
  • IgA Nephropathy
  • Proteinuria
  • End-Stage Kidney Disease
  • Fabry Disease

Clinical work is centered at the University General Hospital of Ioannina.

Cardiovascular Medicine

Investigation of atherosclerotic disease, hypertension and lipid disorders.

  • Atherosclerotic Cardiovascular Disease
  • Elevated Lipoprotein(a)
  • Hypertension
  • Coronary Syndrome
  • Ischemic Stroke

Emphasis on primary prevention and post‑event risk reduction.

Respiratory Medicine

Management of chronic lung diseases and interstitial fibrosis.

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Idiopathic Pulmonary Fibrosis
  • Bronchiectasis
  • Progressive Pulmonary Fibrosis

Includes patients with frequent exacerbations and eosinophilic phenotypes.

Oncology & Hematology

Study of solid tumors and blood cancers across disease stages.

  • Non‑Small Cell Lung Cancer
  • Multiple Myeloma
  • Diffuse Large B‑Cell Lymphoma
  • Acute Myeloid Leukemia
  • Breast Cancer

Research spans targeted therapies and immunotherapy combinations.

Immunology & Inflammatory Diseases

Exploration of immune‑mediated conditions affecting muscle, skin and systemic organs.

  • Idiopathic Inflammatory Myopathy
  • Atopic Dermatitis
  • Ulcerative Colitis
  • Multiple Sclerosis
  • Primary Sjogren's syndrome

Aims to modulate pathogenic cytokine pathways.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.